First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure

被引:59
|
作者
Galeva, S. [1 ,2 ]
Gil, M. M. [1 ,3 ,4 ]
Konstantinidou, L. [1 ]
Akolekar, R. [2 ,5 ]
Nicolaides, K. H. [1 ]
机构
[1] Kings Coll Hosp London, Fetal Med Res Inst, 16-20 Windsor Walk,Denmark Hill, London SE5 8BB, England
[2] Medway Maritime Hosp, Dept Fetal Med, Gillingham, Kent, England
[3] Univ Francisco Vitoria, Sch Hlth Sci, Madrid, Spain
[4] Hosp Univ Torrejon, Obstet & Gynecol Dept, Madrid, Spain
[5] Canterbury Christ Church Univ, Inst Med Sci, Chatham, Kent, England
关键词
cell-free DNA; fetal fraction; first-trimester screening; non-invasive prenatal testing; trisomy; 13; 18; 21; twin pregnancy; CELL-FREE DNA; WEEKS GESTATION RELATION; 1ST TRIMESTER; DOWN-SYNDROME; FETAL; IMPLEMENTATION; ANEUPLOIDIES; IMPACT;
D O I
10.1002/uog.20290
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To examine factors affecting the rate of failure to obtain a result from cell-free DNA (cfDNA) testing of maternal blood for fetal trisomies 21, 18 and 13 in singleton and twin pregnancies in the first trimester. Methods This was a prospective study of 23 495 singleton and 928 twin pregnancies undergoing screening for fetal trisomy by targeted cfDNA testing at 10+0 to 14+1 weeks' gestation. Multivariate logistic regression analysis was used to determine significant predictors of failure to obtain a result after first sampling. Results There was no result from cfDNA testing after first sampling in 3.4% (798/23 495) of singletons, 11.3% (91/806) of dichorionic twins and 4.9% (6/122) of monochorionic twins. Multivariate logistic regression analysis demonstrated that the risk of test failure, first, increased with increasing maternal age (odds ratio (OR), 1.02; 95% CI, 1.01-1.04) and weight (OR, 1.05; 95% CI, 1.04-1.05), decreasing gestational age (OR, 0.85; 95% CI, 0.79-0.91), serum pregnancy-associated plasma protein-A (PAPP-A) multiples of the median (MoM) (OR, 0.56; 95% CI, 0.49-0.65) and free beta-human chorionic gonadotropin (beta-hCG) MoM (OR, 0.67; 95% CI, 0.60-0.74), second, was higher in women of black (OR, 1.72; 95% CI, 1.33-2.20) and South Asian (OR, 1.99; 95% CI, 1.56-2.52) than those of white racial origin, in dichorionic twin than in singleton pregnancy (OR, 1.75; 95% CI, 1.34-2.26) and in pregnancies conceived by in-vitro fertilization than in those conceived naturally (OR, 3.82; 95% CI, 3.19-4.55) and, third, was lower in parous than in nulliparous women (OR, 0.63; 95% CI, 0.55-0.74). Conclusions Maternal age, weight, racial origin and parity, gestational age, dichorionicity, method of conception and serum levels of free beta-hCG and PAPP-A are independent predictors of cfDNA test failure. The risk of test failure is higher in dichorionic twin than in singleton pregnancies, mainly because a higher proportion of twins are conceived by in-vitro fertilization and more of the women are nulliparous. Copyright (c) 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 38 条
  • [21] A comparison between maternal serum free β-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies
    Mashiach, R
    Orr-Urtreger, A
    Yaron, Y
    FETAL DIAGNOSIS AND THERAPY, 2004, 19 (02) : 174 - 177
  • [22] Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10-14 weeks and meta-analysis
    Judah, H.
    Gil, M. M.
    Syngelaki, A.
    Galeva, S.
    Jani, J.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 58 (02) : 178 - 189
  • [23] Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test
    Gil, M. M.
    Revello, R.
    Poon, L. C.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (01) : 45 - 52
  • [24] Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies
    Koster, M. P. H.
    Wortelboer, E. J.
    Stoutenbeek, Ph.
    Visser, G. H. A.
    Schielen, P. C. J. I.
    PRENATAL DIAGNOSIS, 2010, 30 (05) : 413 - 417
  • [25] Does a High-Risk (>1/50) Result for First-Trimester Combined Screening Always Entail Invasive Testing? Which Patients from This Group Might Benefit from cfDNA Testing?
    Garcia-Jimenez, Rocio
    Valero, Irene
    Corrales-Gutierrez, Isabel
    Granell, Reyes
    Borrero, Carlota
    Antonio Sainz-Bueno, Jose
    BIOMEDICINES, 2022, 10 (10)
  • [26] First-trimester screening and small for gestational age in twin pregnancies: a single center cohort study
    Queiros, Alexandra
    Bernardo, Ana
    Rijo, Claudia
    Carocha, Ana
    Ferreira, Leonor
    Martins, Ana Teresa
    Cohen, Alvaro
    Alves, Marta
    Papoila, Ana Luisa
    Simoes, Teresinha
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2025, 311 (01) : 43 - 53
  • [27] First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing
    Nicolaides, K. H.
    Wright, D.
    Poon, L. C.
    Syngelaki, A.
    Gil, M. M.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (01) : 41 - 50
  • [28] A cost-effectiveness analysis comparing two different strategies in advanced maternal age: Combined first-trimester screening and maternal blood cell-free DNA testing
    Pan, Min
    Huang, Lv-Yin
    Zhen, Li
    Li, Dong-Zhi
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (04): : 536 - 540
  • [29] Maternal Reassurance, Satisfaction, and Anxiety after First-Trimester Screening for Aneuploidies: Comparison between Contingent Screening and Universal Cell-Free DNA Testing
    Tramontano, Anna Luna
    Marano, Ilaria
    Orlandi, Giuliana
    Angelino, Antonio
    Rivieccio, Maria
    Fulgione, Caterina
    Maruotti, Giuseppe Maria
    Saccone, Gabriele
    De Vita, Gabriella
    Guida, Maurizio
    Sarno, Laura
    DIAGNOSTICS, 2024, 14 (11)
  • [30] Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers
    Spencer, Kevin
    Kagan, Karl O.
    Nicolaides, Kypros H.
    PRENATAL DIAGNOSIS, 2008, 28 (01) : 49 - 52